Hilda Bastian

Hilda Bastian's avatar
Hilda Bastian
npub1cjnq...05q3
Scientist (PhD; she/her), writer, cartoonist. 🦘 I blog about metascience, science history, epidemiology, grief, social media data, & evidence generally. Following and reporting on next generation Covid vaccines. And I write at The Atlantic sometimes. Newsletter: Living With Evidence https://hildabastian.wordpress.com/ #MetaScience #SystematicReviews #Epidemiology #ClinicalTrials #Grief #Vaccines #Wikipedia #History #HistSci #Science #OpenScience #OpenSocialWeb Living With Evidence (via Mastodon follow): nostr:npub1hc570avkgajuk63zk8dqf2h6nlxgld7n3zq4xyv553c9tt3fdu8sppwv4r Verified by PressCheck.org: https://www.presscheck.org/journalists/hilda-bastian Linktree: https://linktr.ee/hildabastian Wikipedia: https://en.wikipedia.org/wiki/User:Hildabast
A major milestone for next generation Covid vax: The first clinical trial for a pancoronavirus formulation of an existing vaccine was registered. There are more clinical trial results for a vax for people with immunocompromise, & news on mucosal vax trials. Plus 12 preclinical reports. In my monthly update @PLOS :verified: #Vaccines #Covid #Covid19
More progress internationally on next generation Covid vaccines – with a setback in the US: - More good news on the vaccine for people with immunosuppression - Progress in intranasal vaccine trials in France & the US - Approval application for first nextgen vaccine in the US shelved because of new regulations Plus clinical & preclinical results in my update this month @PLOS :verified: now online #Vaccines #Covid #Covid19
A Bumper Month for Covid Vaccines andΒ More It's been an eventful few weeks for Covid vaccines – mostly good, some very bad. Let's start with the good news. Novavax has transferred marketing of its protein subunit Covid vaccine in the EU and US to a major pharmaceutical company, Sanofi. Here's hoping that leads to wider availability and economies of scale. Sanofi will also be able to use Novavax's patented adjuvant in new vaccines.
My latest update on nextgen Covid vaccines is a whopper, in part thanks to catching up with a new vax tracker: - Clinical trial results for 2 vaxes - 3 new clinical trials, incl a phase 2 intranasal vax trial in the US – and a pancoronavirus version of a vaccine that's already been rolled out - 26 preclinical reports, with more showing prevention of transmission &/or durability - a shelf-stable mucosal vax Now @PLOS :verified: #Covid #Covid19 #Vaccines
Have you been noticing the flurries of new or returning people leaving Bluesky due to recent controversies? It got me thinking about how a real Bluesky exodus would play out, and digging into the studies of the 2022 Mastodon migration from Twitter. I found 14 studies. TLDR; a Bluesky flight would be different. Here's my new post @PLOS :verified: :
A big month for progress on mucosal Covid vaccines! - A 35th mucosal vax in clinical trial - Encouraging preclinical results for intranasal self-amplifying mRNA vax from Spain - News on progress with the Covid infection studies laying the groundwork for testing mucosal vax in human challenge studies Plus more clinical results for self-amplifying mRNA vax & fascinating pandemic preparedness news from Singapore Nextgen Covid vax update @PLOS :verified: #Covid #Covid19 #Vaccines
My next generation Covid vaccine update this month includes a surprise new phase 1 trial funded by US Project NextGen, & some trial results. Plus 10 new preclinical reports, mostly for mucosal vaccines. Now out @PLOS :verified: : #Covid #Covid19 #Vaccines